Pelvic external beam radiotherapy

RADIATION2 trials

Sponsors

Leiden University Medical Center, Peking Union Medical College Hospital

Conditions

Adjuvant RadiotherapyEndometrial CancerMolecular Classification

Phase 2

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

RecruitingNCT05255653

Leiden University Medical CenterEndometrial Cancer

Start: 2021-11-11End: 2031-01-01Target: 1615Updated: 2026-05-15

Phase 3

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Not yet recruitingNCT05524389

Peking Union Medical College HospitalAdjuvant Radiotherapy, Endometrial Cancer, Molecular Classification

Start: 2022-12-01End: 2027-06-30Target: 624Updated: 2022-11-23

Related Papers

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.

2025-02-111 citations

The RAINBO MMRd-GREEN trial (GCIG/DGOG/ENGOT-EN14<sup>2</sup>): A phase III trial on the addition of adjuvant durvalumab to radiotherapy in patients with high-risk MMRd endometrial cancer.

Journal of Clinical Oncology2023-06-014 citations

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.

2023-01-03129 citations